Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics

被引：0
|
作者：
Yun, Jiwon [1 ]
Kim, Jung-Ah [2 ]
Hwang, Byungjin [3 ]
Park, Hee Sue [4 ]
Im, Kyongok [5 ,6 ]
Kim, Sung-Min [7 ]
Jeong, Dajeong [1 ]
Lim, Kyu Min [7 ]
Bang, Duhee [3 ]
Lee, Dong Soon [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[2] Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea
[4] Chungbuk Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[5] Inst Reprod Med, Seoul, South Korea
[6] Populat Med Res Ctr, Seoul, South Korea
[7] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
来源：
BLOOD | 2018年 / 132卷
关键词：
Myeloproliferative neoplasms; next-generation sequencing; triple negative MPN; chromosome; FISH; telomere;
D O I：
10.1182/blood-2018-99-118013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Molecular testing for JAK2, MPL, and CALR in myeloproliferative neoplasms
    Xia, Daniel
    Hasserjian, Robert P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1277 - 1280
  • [2] Calr Vs. JAK2 Vs. MPL Mutations in the Progression of Philadelphia-Negative Myeloproliferative Neoplasms
    Bai, Jie
    Sheng, Mengyao
    Xing, Wen
    Bai, Jiaojiao
    Li, Rong
    Shi, Jun
    Zhang, Lei
    Yuan, Weiping
    Yang, Feng-Chun
    Zhou, Yuan
    BLOOD, 2017, 130
  • [3] The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
    Jones, Amy V.
    Campbell, Peter J.
    Beer, Philip A.
    Schnittger, Susanne
    Vannucchi, Alessandro M.
    Zoi, Katerina
    Percy, Melanie J.
    McMullin, Mary Frances
    Scott, Linda M.
    Tapper, William
    Silver, Richard T.
    Oscier, David
    Harrison, Claire N.
    Grallert, Harald
    Kisialiou, Aliaksei
    Strike, Paul
    Chase, Andrew J.
    Green, Anthony R.
    Cross, Nicholas C. P.
    BLOOD, 2010, 115 (22) : 4517 - 4523
  • [4] CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
    Tefferi, A.
    Lasho, T. L.
    Finke, C. M.
    Knudson, R. A.
    Ketterling, R.
    Hanson, C. H.
    Maffioli, M.
    Caramazza, D.
    Passamonti, F.
    Pardanani, A.
    LEUKEMIA, 2014, 28 (07) : 1472 - 1477
  • [5] CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
    A Tefferi
    T L Lasho
    C M Finke
    R A Knudson
    R Ketterling
    C H Hanson
    M Maffioli
    D Caramazza
    F Passamonti
    A Pardanani
    Leukemia, 2014, 28 : 1472 - 1477
  • [6] JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms
    Pietra, Daniela
    Casetti, Ilaria
    Da Via, Matteo C.
    Elena, Chiara
    Milanesi, Chiara
    Rumi, Elisa
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (07) : 746 - 747
  • [7] JAK2 and MPL mutations in myeloproliferative neoplasms
    Koppikar, Priya
    Levine, Ross L.
    ACTA HAEMATOLOGICA, 2008, 119 (04) : 218 - 225
  • [8] JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
    Shirane, Shuichi
    Araki, Marito
    Morishita, Soji
    Edahiro, Yoko
    Takei, Hiraku
    Yoo, Yongjin
    Choi, Murim
    Sunami, Yoshitaka
    Hironaka, Yumi
    Noguchi, Masaaki
    Koike, Michiaki
    Noda, Naohiro
    Ohsaka, Akimichi
    Komatsu, Norio
    HAEMATOLOGICA, 2015, 100 (02) : E46 - E48
  • [9] Clinical outcomes of patients with JAK2, CALR and MPL positive myeloproliferative neoplasms
    Komic, H.
    Islamagic, E.
    Kurtovic, S.
    Burekovic, A.
    Uzunovic, A.
    Kurtovic-Kozaric, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1841 - 1842
  • [10] Morphology and histotopography of megakaryocytes in Ph-negative JAK2-mutated, CALR-mutated and triple-negative myeloproliferative neoplasms
    Gogoleva, D.
    Sychugov, G.
    VIRCHOWS ARCHIV, 2020, 477 : S98 - S98
12345